Literature DB >> 23657999

Absolute measurement of species differences in sodium taurocholate cotransporting polypeptide (NTCP/Ntcp) and its modulation in cultured hepatocytes.

Xi Qiu1, Yi-An Bi, Larissa M Balogh, Yurong Lai.   

Abstract

Species differences among membrane transporters can be remarkable and difficult to properly assess by conventional methods. Herein, we employed the first use of stable isotope labeling in mammals or stable isotope-labeled peptides combined with mass spectrometry to identify species differences in sodium taurocholate cotransporting polypeptide (NTCP/Ntcp) protein expression in liver tissue and to characterize the modulation of protein expression in sandwich-cultured human (SCHH) and rat hepatocytes (SCRH). The lower limit of quantification was established to be 5 fmol on column with a standard curve that was linear up to 2000 fmol. The accuracy and precision were evaluated with three quality control samples and known amounts of synthetic proteotypic peptides that were spiked into the membrane protein extracts. The overall relative error and coefficient of variation were less than 10%. The expression of Ntcp in mouse and rat was significant higher than that in human (five-fold) and monkey (two-fold) and ranked as mouse > rat >> monkey > human. In the cultured hepatocytes, although significant downregulation of Ntcp expression in SCRH at day 5 after the culture was detected, NTCP expression in SCHH was comparable to the suspension hepatocytes. The results suggested that NTCP/Ntcp modulation in cultured hepatocytes is species specific.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  LC-MS/MS; NTCP; hepatic transport; hepatocytes; target proteomics; transporters

Mesh:

Substances:

Year:  2013        PMID: 23657999     DOI: 10.1002/jps.23582

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  11 in total

Review 1.  Mass spectrometry-based targeted proteomics as a tool to elucidate the expression and function of intestinal drug transporters.

Authors:  Stefan Oswald; Christian Gröer; Marek Drozdzik; Werner Siegmund
Journal:  AAPS J       Date:  2013-08-28       Impact factor: 4.009

Review 2.  Optimized approaches for quantification of drug transporters in tissues and cells by MRM proteomics.

Authors:  Bhagwat Prasad; Jashvant D Unadkat
Journal:  AAPS J       Date:  2014-04-22       Impact factor: 4.009

Review 3.  Quantitative targeted proteomics for membrane transporter proteins: method and application.

Authors:  Xi Qiu; Hui Zhang; Yurong Lai
Journal:  AAPS J       Date:  2014-05-15       Impact factor: 4.009

Review 4.  Critical Issues and Optimized Practices in Quantification of Protein Abundance Level to Determine Interindividual Variability in DMET Proteins by LC-MS/MS Proteomics.

Authors:  Deepak Kumar Bhatt; Bhagwat Prasad
Journal:  Clin Pharmacol Ther       Date:  2017-09-25       Impact factor: 6.875

Review 5.  Applications of human hepatitis B virus preS domain in bio- and nanotechnology.

Authors:  Riki Toita; Takahito Kawano; Jeong-Hun Kang; Masaharu Murata
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

6.  Endogenous antiviral microRNAs determine permissiveness for hepatitis B virus replication in cultured human fetal and adult hepatocytes.

Authors:  Mukesh Kumar; Yogeshwar Sharma; Sriram Bandi; Sanjeev Gupta
Journal:  J Med Virol       Date:  2015-02-17       Impact factor: 2.327

Review 7.  Prediction of pharmacokinetics and drug-drug interactions when hepatic transporters are involved.

Authors:  Rui Li; Hugh A Barton; Manthena V Varma
Journal:  Clin Pharmacokinet       Date:  2014-08       Impact factor: 6.447

8.  Abundance of Hepatic Transporters in Caucasians: A Meta-Analysis.

Authors:  Howard J Burt; Arian Emami Riedmaier; Matthew D Harwood; H Kim Crewe; Katherine L Gill; Sibylle Neuhoff
Journal:  Drug Metab Dispos       Date:  2016-08-04       Impact factor: 3.922

9.  Database of Optimized Proteomic Quantitative Methods for Human Drug Disposition-Related Proteins for Applications in Physiologically Based Pharmacokinetic Modeling.

Authors:  M Vrana; D Whittington; V Nautiyal; B Prasad
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2017-04-04

10.  Comparative untargeted proteomic analysis of ADME proteins and tumor antigens for tumor cell lines.

Authors:  Xiaomei Gu; Qing Xiao; Qian Ruan; Yuezhong Shu; Ashok Dongre; Ramaswamy Iyer; W Griffith Humphreys; Yurong Lai
Journal:  Acta Pharm Sin B       Date:  2017-11-04       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.